{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:21:11Z","timestamp":1784557271200,"version":"3.55.0"},"reference-count":0,"publisher":"Bioscientifica","issue":"3","content-domain":{"domain":["joe.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:p>\n                    Thyroid hormone (TH) levels increase rapidly during the prepubertal growth period in mice, and this change is necessary for endochondral ossification of the epiphyses. This effect of TH on epiphyseal chondrocyte hypertrophy is mediated via TR\u03b21. In addition to its traditional genomic signaling role as a transcription factor, TR\u03b21 can also exert nongenomic effects by interacting with other signaling molecules such as PI3K. To investigate the role of nongenomic TR\u03b21 signaling in endochondral ossification, we evaluated the skeletal phenotype of TR\u03b2147F mutant mice which exhibit a normal genomic response of TR\u03b21 to TH, but the nongenomic response through the PI3K pathway is impaired. Using microCT, we found that 13-week-old TR\u03b2147F mice had significantly less trabecular bone mass at three sites. Histomorphometric analyses revealed that mineralizing surface to bone surface and BFR\/BS were reduced in the mutant mice. Mechanistically, we found that activation of TR\u03b2 increased\n                    <jats:italic>Alp<\/jats:italic>\n                    and\n                    <jats:italic>Osx<\/jats:italic>\n                    expression in control but not TR\u03b2147F osteoblasts. Since canonical \u03b2-catenin signaling has been implicated in mediating nongenomic TR\u03b2\u2013PI3K signaling, we evaluated the effect of TR\u03b21 activation on \u03b2-catenin target gene expression in MC3T3-E1 pre-osteoblasts. We found that \u03b2-catenin target genes were increased, suggesting that nongenomic TR\u03b21\u2013PI3K pathway modulation of \u03b2-catenin signaling may mediate TR\u03b21 effects on osteoblast differentiation. Together, these results suggest that TH acting through TR\u03b21 regulates endochondral ossification in part via nongenomic signaling in mice. Further investigation of this nongenomic mechanism of TR\u03b21 signaling could lead to novel therapeutic targets for treatment and prevention of osteoporosis.\n                  <\/jats:p>","DOI":"10.1530\/joe-19-0172","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T08:07:22Z","timestamp":1561709242000},"page":"173-183","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-5","source":"Crossref","is-referenced-by-count":7,"title":["Skeletal effects of nongenomic thyroid hormone receptor beta signaling"],"prefix":"10.1530","volume":"242","author":[{"given":"Richard C","family":"Lindsey","sequence":"first","affiliation":[{"name":"1Musculoskeletal Disease Center, VA Loma Linda Healthcare System, Loma Linda, California, USA"},{"name":"2Center for Health Disparities and Molecular Medicine, School of Medicine, Loma Linda University, Loma Linda, California, USA"},{"name":"3Division of Biochemistry, Department of Basic Sciences, School of Medicine, Loma Linda University, Loma Linda, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catrina","family":"Godwin","sequence":"additional","affiliation":[{"name":"1Musculoskeletal Disease Center, VA Loma Linda Healthcare System, Loma Linda, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subburaman","family":"Mohan","sequence":"additional","affiliation":[{"name":"1Musculoskeletal Disease Center, VA Loma Linda Healthcare System, Loma Linda, California, USA"},{"name":"2Center for Health Disparities and Molecular Medicine, School of Medicine, Loma Linda University, Loma Linda, California, USA"},{"name":"3Division of Biochemistry, Department of Basic Sciences, School of Medicine, Loma Linda University, Loma Linda, California, USA"},{"name":"4Department of Medicine, School of Medicine, Loma Linda University, Loma Linda, California, USA"},{"name":"5Department of Orthopedics, School of Medicine, Loma Linda University, Loma Linda, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","container-title":["Journal of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/joe.bioscientifica.com\/view\/journals\/joe\/242\/3\/JOE-19-0172.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/joe.bioscientifica.com\/downloadpdf\/journals\/joe\/242\/3\/JOE-19-0172.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:56:48Z","timestamp":1784555808000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/joe\/article\/242\/3\/173-183\/5163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":0,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1530\/joe-19-0172","relation":{},"ISSN":["0022-0795","1479-6805"],"issn-type":[{"value":"0022-0795","type":"print"},{"value":"1479-6805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}